Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal Surgery.

IF 2.8 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics
Therapeutics and Clinical Risk Management Pub Date : 2025-10-11 eCollection Date: 2025-01-01 DOI:10.2147/TCRM.S543913
Daantje N Gratama, Laurence Weinberg, Nattaya Raykateeraroj, Je Min A Suh, Junyan Zhao, Elizabeth P Hu, Vidhura Ratnasekara, Thomas Freeman, David S Liu, Alexandre Joosten, Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Dong-Kyu Lee
{"title":"Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal Surgery.","authors":"Daantje N Gratama, Laurence Weinberg, Nattaya Raykateeraroj, Je Min A Suh, Junyan Zhao, Elizabeth P Hu, Vidhura Ratnasekara, Thomas Freeman, David S Liu, Alexandre Joosten, Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Dong-Kyu Lee","doi":"10.2147/TCRM.S543913","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored.</p><p><strong>Patients and methods: </strong>1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality.</p><p><strong>Results: </strong>Median age was 64 years (IQR 53-74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3-25.6%; <i>P</i><0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83-33.0; <i>P</i><0.001).</p><p><strong>Conclusion: </strong>Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1459-1472"},"PeriodicalIF":2.8000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12523569/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutics and Clinical Risk Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S543913","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: We primarily evaluated the relationship between postoperative complications and long-term survival in patients undergoing major gastrointestinal surgery. Secondarily, we investigated the relationship between the severity and the number of complications and long-term survival. While postoperative complications are prevalent after major abdominal surgery and associated with increased mortality, the effect of their severity and accumulation remains insufficiently explored.

Patients and methods: 1989 adult patients undergoing major gastrointestinal surgery between July 2010 and April 2022 were retrospectively studied. Complications were classified using the Clavien-Dindo system. Kaplan-Meier analysis assessed long-term survival, Cox proportional hazards regression with time-dependent coefficients evaluated the impact of complications on mortality.

Results: Median age was 64 years (IQR 53-74); 41.8% female and 63.0% of patients were diagnosed with malignancy. Elective procedures comprised 73.0% of cases. Complications occurred in 74.6% of patients. Mortality was higher in patients with complications (32.0%, 95% CI 29.7%-34.5%), compared to those without (21.7%, 95% CI 18.3-25.6%; P<0.001). Severe complications (Clavien-Dindo Grade ≥III) were associated with a 15.01-fold higher hazard of mortality within 18 months postoperatively (95% CI 6.83-33.0; P<0.001).

Conclusion: Postoperative complications significantly reduce long-term survival following major gastrointestinal surgery. Both their severity and frequency are critical determinants of poorer outcomes, emphasizing the need for effective prevention strategies.

Abstract Image

Abstract Image

Abstract Image

降低大胃肠手术术后并发症后的长期生存率。
目的:我们主要评估胃肠大手术患者术后并发症与长期生存的关系。其次,我们调查了并发症的严重程度和数量与长期生存的关系。虽然术后并发症在腹部大手术后很普遍,并与死亡率增加有关,但其严重程度和积累的影响仍未得到充分探讨。患者与方法:对2010年7月至2022年4月期间接受胃肠大手术的1989例成人患者进行回顾性研究。采用Clavien-Dindo系统对并发症进行分类。Kaplan-Meier分析评估长期生存率,Cox时间相关系数比例风险回归评估并发症对死亡率的影响。结果:中位年龄64岁(IQR 53 ~ 74);女性占41.8%,恶性肿瘤占63.0%。选择性手术占73.0%。74.6%的患者出现并发症。有并发症患者的死亡率(32.0%,95% CI 29.7%-34.5%)高于无并发症患者(21.7%,95% CI 18.3-25.6%)。结论:术后并发症显著降低胃肠道大手术后的长期生存率。其严重程度和频率都是较差结果的关键决定因素,强调需要有效的预防战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management HEALTH CARE SCIENCES & SERVICES-
CiteScore
5.30
自引率
3.60%
发文量
139
审稿时长
16 weeks
期刊介绍: Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信